VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mkilloran who wrote (19956)	3/21/1999 9:46:00 PM
From: VLAD	Read Replies (1) of 23519

martin, I'm not too impressed with the analysts covering Vivus. I'd like to see some new coverage initiated by the likes of Merrill Lynch or some other large brokerage and expect this to occur soon. ASA Vivus finds a partner, CS First Boston can resume making a market in Vivus and coverage since it will no longer be needed to negotiate anything. I haven't seen any type of recent report on Vivus via Cruttendon Roth or Genesis Merchant. I don't have a lot of respect for the Genesis analyst as I feel he sold out on the Fulgham study during last years AAU meeting. Cruttendon Roth on the other hand has earned a bad wrap after Wole Fayemi kept banging the table. Actually I feel sorry for Wole as I think his call was correct but his timing stunk. Wole along with many others didn't expect the FDA to allow Pfizer carte blanche with Viagra. My hat is off to Charlie O as he maintained his strong buy even as the stock lingered in the 2's. I expect to soon hear some sort of updated report from Charlie O at Paine Webber that should give a positive future outlook for Vivus.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next